Health Partners, the UK’s largest non-hospital
private healthcare services provider, with more than two million
patients across 500+ corporate, insurance and government clients,
announces partnership with MedX Health to launch a pilot program of
MedX’s DermSecure® Screening Platform
MedX Health Corp. ("MedX" or the "Company") (TSXV:
MDX), a global leader in teledermatology, is pleased to
announce a Memorandum of Understanding (“MOU”) and the launch of a
new commercialization pilot project with Health Partners (OH)
Limited, a well-respected, privately-owned corporate health,
treatment and primary care services company in the United Kingdom.
Serving a broad client base comprising corporates, government
agencies, insurers, health trusts, pension funds and individuals,
Health Partners (“HP”) employs 700+ people with telehealth, mobile
and on-site operations across the UK and the Republic of
Ireland.
The pilot will span three to six months and involve an estimated
600 patients across two of HP’s sites. Upon the successful
completion of the pilot, the MedX DermSecure® Screening Platform
will be made available to Health Partners' two million-plus
patients. The agreement is the latest initiative in MedX’s global
commercialization strategy and follows pilots recently launched
across the Europe and Middle East region.
"Health Partners’ Clinical Team constantly strives to identify
leading technological innovations that offer the highest level of
support to our two million-plus patients," said Health Partners
Managing Director Andrew Noble. “MedX's leading skin assessment
technology allows dermatologists to not only make more accurate
diagnoses of pigmented lesions and moles, but to do that remotely
and quickly. We are very proud to be partnering with MedX Health to
bring this innovative and life-changing service to our
clients.”
In addition to expanding its DermSecure® Screening Platform
network globally, MedX has focused on building a presence in
multiple market verticals such as pharmacies, medical clinics,
building hubs, medical scanning clinics, mobile and remote medical
practices, as well as esthetics and skincare clinics. The
partnership with Health Partners represents MedX’s expansion into a
new vertical; occupational health and wellbeing services.
MedX Managing Director, Europe, Middle East and Africa (EMEA),
Naman Demaghlatrous, added, "MedX is pleased to have established a
presence in the strategic occupational health vertical. Health
Partners brings our technology to a population of more than two
million workers across the United Kingdom, thus expanding our
footprint in the EMEA region considerably. We continue to execute
on our strategy to identify strategic partnerships in the region
that will allow us to grow our business and save lives
simultaneously.”
Health Partners will pilot MedX’s high-definition image-capture
technology, SIAscopy®, and its secure, cloud-based patient
management system, DermSecure®, which transmits and stores patient
data throughout the assessment process. MedX's SIAscopy® is the
only technology available that captures five high-resolution images
of suspicious moles, lesions and skin conditions, including four
spectrophotometric images taken 2mm below the skin's surface. This
technology provides detailed patient scans, which a certified
dermatologist can virtually assess within 72 hours.
"We are honoured to be working with Health Partners on this most
important initiative. According to Health & Safety
Executive-commissioned research, there are more than 3,000 cases of
skin cancer annually in the construction industry alone. We are
delighted to be entering the occupational health services market
with a leader in the industry," stated Mike Druhan, MedX President,
Dermatology Services.
About Health Partners (OH) Ltd.
Health Partners, headquartered in Uckfield, East Sussex, United
Kingdom, is a leading health and wellbeing company, providing a
full range of corporate health, treatment and primary care services
to corporates, government, insurers, health trusts, pension funds
and families. We combine expert advice and clinical services with
smart systems to deliver impact-driven health programmes, tailored
to improve people’s wellbeing and performance.
Health Partners is founded on patient privacy and holds a
significant number of accreditations, certifications and
memberships, including ISO27001, CQC, SEQOHS and ISO9001. Health
Partners offers its services across the United Kingdom and the
Republic of Ireland, reaching two million plus people in
organisations across several industries. For more information,
visit www.healthpartners.uk.com.
About MedX Health Corp.
MedX, headquartered in Ontario, Canada, is a leading medical
device and software company focused on skin health with its
SIAscopy® on DermSecure® telemedicine platform, utilizing its
SIAscopy® technology. SIAscopy® is also imbedded in its products
SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its
ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate®
include hand-held devices that use patented technology utilizing
light and its remittance to view suspicious moles and lesions up to
2mm beneath in a pain-free, non-invasive manner. Its patented
software then creates real-time images for physicians and
dermatologists to evaluate all types of moles or lesions within
seconds. These products are cleared by Health Canada, the U.S. Food
and Drug Administration, the Therapeutic Goods Administration and
Conformité Européenne for use in Canada, the U.S., Australia, New
Zealand, the European Union, Brazil and Turkey. For more
information, visit www.medxhealth.com.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This Media Release may contain forward-looking statements,
which reflect the Company's current expectations regarding future
events. The forward-looking statements involve risks and
uncertainties.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220302005737/en/
Bill Mitoulas, Investor Relations MedX Health Corp.
bill@medxhealth.com +1-416-479-9547
Medx Health (TSXV:MDX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medx Health (TSXV:MDX)
Historical Stock Chart
From Nov 2023 to Nov 2024